Published in Vaccine on July 20, 2001
Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci U S A (2006) 1.58
Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One (2009) 1.08
A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks. J Virol (2011) 1.02
Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice. PLoS One (2012) 0.82
In vitro and in vivo relevance of infectious laryngotracheitis virus gJ proteins that are expressed from spliced and nonspliced mRNAs. J Virol (2005) 0.81
Infectious laryngotracheitis virus in chickens. World J Virol (2012) 0.79
Evaluation of a Subunit H5 Vaccine and an Inactivated H5N2 Avian Influenza Marker Vaccine in Ducks Challenged with Vietnamese H5N1 Highly Pathogenic Avian Influenza Virus. Influenza Res Treat (2010) 0.79
Viral vector-based influenza vaccines. Hum Vaccin Immunother (2016) 0.79
Recombinant Marek's Disease Virus as a Vector-Based Vaccine against Avian Leukosis Virus Subgroup J in Chicken. Viruses (2016) 0.75
Ultrastructural analysis of the replication cycle of pseudorabies virus in cell culture: a reassessment. J Virol (1997) 3.29
Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J Virol (1991) 3.00
Egress of alphaherpesviruses: comparative ultrastructural study. J Virol (2001) 2.92
Primary envelopment of pseudorabies virus at the nuclear membrane requires the UL34 gene product. J Virol (2000) 2.91
Pseudorabies virus avirulent strains fail to express a major glycoprotein. J Virol (1985) 2.70
Inhibition of virion maturation by simultaneous deletion of glycoproteins E, I, and M of pseudorabies virus. J Virol (1999) 2.52
Phylogenetic analyses of highly pathogenic avian influenza virus isolates from Germany in 2006 and 2007 suggest at least three separate introductions of H5N1 virus. Vet Microbiol (2007) 2.34
Complex between glycoproteins gI and gp63 of pseudorabies virus: its effect on virus replication. J Virol (1988) 2.24
Effect of the pseudorabies virus US3 protein on nuclear membrane localization of the UL34 protein and virus egress from the nucleus. J Gen Virol (2001) 2.23
Role of the cytoplasmic tail of pseudorabies virus glycoprotein E in virion formation. J Virol (2000) 2.17
Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulfide-linked glycoprotein complex. J Virol (1985) 2.14
Role of pseudorabies virus glycoprotein gI in virus release from infected cells. J Virol (1987) 2.11
Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J Virol (2000) 2.10
Glycoprotein gIII of pseudorabies virus is multifunctional. J Virol (1988) 2.05
Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum. J Mol Med (Berl) (2000) 2.04
Pseudorabies virus UL37 gene product is involved in secondary envelopment. J Virol (2001) 2.01
Pseudorabies virus glycoprotein M inhibits membrane fusion. J Virol (2000) 1.94
Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science (1995) 1.93
Two novel genetic groups (VIIb and VIII) responsible for recent Newcastle disease outbreaks in Southern Africa, one (VIIb) of which reached Southern Europe. Arch Virol (1999) 1.88
Current-voltage curve of sodium channels and concentration dependence of sodium permeability in frog skin. J Physiol (1977) 1.83
Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J (1995) 1.82
Glycoproteins M and N of pseudorabies virus form a disulfide-linked complex. J Virol (1998) 1.79
Mapping of the structural gene of pseudorabies virus glycoprotein A and identification of two non-glycosylated precursor polypeptides. J Virol (1985) 1.78
Newcastle disease outbreaks in recent years in western Europe were caused by an old (VI) and a novel genotype (VII). Arch Virol (1998) 1.76
Role of envelope glycoproteins gI, gp63 and gIII in the invasion and spread of Aujeszky's disease virus in the olfactory nervous pathway of the pig. J Gen Virol (1994) 1.73
Deletion of glycoprotein gE reduces the propagation of pseudorabies virus in the nervous system of mice after intranasal inoculation. Virology (1996) 1.72
Glycoproteins gIII and gp50 play dominant roles in the biphasic attachment of pseudorabies virus. Virology (1993) 1.72
Glycoprotein gL-independent infectivity of pseudorabies virus is mediated by a gD-gH fusion protein. J Virol (1999) 1.70
Pathology of natural infections by H5N1 highly pathogenic avian influenza virus in mute (Cygnus olor) and whooper (Cygnus cygnus) swans. Vet Pathol (2007) 1.70
Effects of truncation of the carboxy terminus of pseudorabies virus glycoprotein B on infectivity. J Virol (2000) 1.67
Identification and characterization of the pseudorabies virus UL3.5 protein, which is involved in virus egress. J Virol (1996) 1.66
Type- and subtype-specific RT-PCR assays for avian influenza A viruses (AIV). J Vet Med B Infect Dis Vet Public Health (2000) 1.65
Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1. J Virol (1991) 1.64
Pseudorabies virus glycoprotein L is necessary for virus infectivity but dispensable for virion localization of glycoprotein H. J Virol (1997) 1.59
Giant retinal tears. Surgical techniques and results using perfluorocarbon liquids. Arch Ophthalmol (1989) 1.57
The UL20 gene product of pseudorabies virus functions in virus egress. J Virol (1997) 1.52
Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol (1999) 1.50
Pseudorabies virus glycoprotein K requires the UL20 gene product for processing. J Virol (2000) 1.49
Identification and characterization of pseudorabies virus glycoprotein gM as a nonessential virion component. J Virol (1996) 1.48
Pseudorabies virus glycoprotein gK is a virion structural component involved in virus release but is not required for entry. J Virol (1998) 1.44
Sequence and expression of the glycoprotein gH gene of pseudorabies virus. Virology (1991) 1.43
Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res (1997) 1.42
Uncompensated blood loss is not tolerated during acute normovolemic hemodilution in anesthetized pigs. Anesth Analg (1998) 1.42
Role of essential glycoproteins gII and gp50 in transneuronal transfer of pseudorabies virus from the hypoglossal nerves of mice. J Virol (1993) 1.41
Stable rescue of a glycoprotein gII deletion mutant of pseudorabies virus by glycoprotein gI of bovine herpesvirus 1. J Virol (1992) 1.41
A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structure. J Mol Med (Berl) (2000) 1.39
Glycoprotein gH of pseudorabies virus is essential for penetration and propagation in cell culture and in the nervous system of mice. J Gen Virol (1996) 1.39
Green fluorescent protein expressed by recombinant pseudorabies virus as an in vivo marker for viral replication. J Virol Methods (1997) 1.38
Mutations affecting the UL21 gene contribute to avirulence of pseudorabies virus vaccine strain Bartha. Virology (1995) 1.38
Glycoprotein IV of bovine herpesvirus 1-expressing cell line complements and rescues a conditionally lethal viral mutant. J Virol (1992) 1.37
Epidemiological and ornithological aspects of outbreaks of highly pathogenic avian influenza virus H5N1 of Asian lineage in wild birds in Germany, 2006 and 2007. Transbound Emerg Dis (2009) 1.37
Identification and characterization of a novel structural glycoprotein in pseudorabies virus, gL. J Virol (1994) 1.36
The UL49.5 gene of pseudorabies virus codes for an O-glycosylated structural protein of the viral envelope. J Virol (1996) 1.36
Pseudorabies virus in wild swine: a global perspective. Arch Virol (2011) 1.33
Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation. Proc Natl Acad Sci U S A (1980) 1.33
Location of the structural gene of pseudorabies virus glycoprotein complex gII. Virology (1986) 1.32
Synaptic and neurotransmitter activation of cardiac vagal neurons in the nucleus ambiguus. Ann N Y Acad Sci (2001) 1.32
Propagation of pseudorabies virus in the nervous system of the mouse after intranasal inoculation. Virology (1994) 1.30
Rapid molecular subtyping by reverse transcription polymerase chain reaction of the neuraminidase gene of avian influenza A viruses. Vet Microbiol (2008) 1.29
Pseudorabies virus and equine herpesvirus 1 share a nonessential gene which is absent in other herpesviruses and located adjacent to a highly conserved gene cluster. J Virol (1995) 1.28
Herpesvirus (pseudorabies virus) latency in swine: occurrence and physical state of viral DNA in neural tissues. Virology (1986) 1.26
Identification and characterization of pseudorabies virus glycoprotein H. J Virol (1992) 1.26
Adaptability in herpesviruses: glycoprotein D-independent infectivity of pseudorabies virus. J Virol (1997) 1.24
Liberation of N-acetylglucosamine-6-sulfate by human beta-N-acetylhexosaminidase A. J Biol Chem (1981) 1.23
Invasion and spread of single glycoprotein deleted mutants of Aujeszky's disease virus (ADV) in the trigeminal nervous pathway of pigs after intranasal inoculation. Vet Microbiol (1994) 1.22
Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor. Mol Cell Biol (1999) 1.21
Distribution of lesions and antigen of highly pathogenic avian influenza virus A/Swan/Germany/R65/06 (H5N1) in domestic cats after presumptive infection by wild birds. Vet Pathol (2007) 1.21
Intracellular processing of pseudorabies virus glycoprotein M (gM): gM of strain Bartha lacks N-glycosylation. Virology (1997) 1.20
Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine. J Virol (1993) 1.20
Suprachiasmatic nucleus: a central autonomic clock. Nat Neurosci (1999) 1.20
Perfluorocarbon gases in vitreous surgery. Ophthalmology (1985) 1.20
Release of pseudorabies virus from infected cells is controlled by several viral functions and is modulated by cellular components. J Virol (1989) 1.17
Cell surface proteoglycans are not essential for infection by pseudorabies virus. J Virol (1995) 1.17
Deletion of glycoprotein gM of pseudorabies virus results in attenuation for the natural host. J Gen Virol (1997) 1.14
Encephalitis in a stone marten (Martes foina) after natural infection with highly pathogenic avian influenza virus subtype H5N1. J Comp Pathol (2007) 1.13
DNA sequence and transcriptional analysis of the UL1 to UL5 gene cluster of infectious laryngotracheitis virus. J Gen Virol (1996) 1.13
DNA sequence of the UL6 to UL20 genes of infectious laryngotracheitis virus and characterization of the UL10 gene product as a nonglycosylated and nonessential virion protein. J Gen Virol (1999) 1.10
Establishment of a competitive ELISA (cELISA) system for the detection of influenza A virus nucleoprotein antibodies and its application to field sera from different species. J Vet Med B Infect Dis Vet Public Health (2006) 1.10
Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes. J Gen Virol (1990) 1.10
An analyzer for in-line measurement of expiratory sulfur hexafluoride concentration. Anesthesiology (1985) 1.09
CNS inputs to the suprachiasmatic nucleus of the rat. Neuroscience (2002) 1.08
Protection of pigs against Aujeszky's disease by DNA vaccination. J Gen Virol (1997) 1.08
Eradication of Aujeszky's disease in Germany. J Vet Med B Infect Dis Vet Public Health (2003) 1.08
Diagnosis of pseudoxanthoma elasticum by scar biopsy in patients without characteristic skin lesions. N Engl J Med (1987) 1.07
Identification and characterization of pseudorabies virus dUTPase. J Virol (1996) 1.07
A second form of infectious bursal disease virus-associated tubule contains VP4. J Virol (1997) 1.07
Complete genomic sequence of the fish rhabdovirus infectious haematopoietic necrosis virus. J Gen Virol (1995) 1.06
Neurotropism of highly pathogenic avian influenza virus A/chicken/Indonesia/2003 (H5N1) in experimentally infected pigeons (Columbia livia f. domestica). Vet Pathol (2006) 1.06
Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes. J Virol (1990) 1.06
Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells. J Virol (1997) 1.05
Ventilation inhomogeneity during controlled ventilation. Which index should be used? J Appl Physiol (1985) (1988) 1.05
Firefly luciferase as a marker for herpesvirus (pseudorabies virus) replication in vitro and in vivo. J Gen Virol (1991) 1.04
Single CNS neurons link both central motor and cardiosympathetic systems: a double-virus tracing study. Neuroscience (2003) 1.04
Tay-Sachs disease: one-step assay of beta-N-acetylhexosaminidase in serum with a sulphated chromogenic substrate. Clin Chim Acta (1983) 1.03